Cell and Gene Therapy News

Two Baylor College of Medicine faculty members named to National Academy of MedicineOct 17, 2016
Dr. Malcolm Brenner and Dr. Cheryl Walker were elected to membership in the National Academy of Medicine.
Special T cells that target solid tumors offer potential treatment for pediatric and adult cancersSep 14, 2016
A new study by researchers at Baylor College of Medicine and Texas Children’s Cancer Center has shown promising results for the use of adoptive cell-therapies to treat pediatric and adult solid tumor cancers.
One-time treatment rescues lethal metabolic liver disease in miceAug 30, 2016
Researchers have shown in mice that deleting a gene associated with liver disorder tyrosinaemia type I, they can turn the once deadly illness benign.
T cells that target two tumor surface molecules mitigate tumor escape in mouse model of glioblastomaJul 18, 2016
Researchers show a new strategy, based on targeting specific surface molecules, that eliminates most of the cancer cells in a mouse model of glioblastoma.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responsesJun 6, 2016
Treating B cell malignancies with the patients’ own T cells modified so as to target specific B cell markers has shown clinical success.
Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancerApr 4, 2016
Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
Heslop named director of Center for Cell and Gene TherapyApr 1, 2016
The Baylor College of Medicine Board of Trustees named Dr. Helen Heslop as director of the Center for Cell and Gene Therapy.
Grants support Baylor researchers’ work on immunotherapy for leukemiaOct 2, 2015
Two Baylor researchers have received Translational Research Grants for projects that use immunotherapy approaches to treat leukemia.
Safety switch preserves beneficial effects of cell therapyMay 14, 2015
Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Novel cell therapy from 'naïve' cells recognizes, attacks high-risk viruses for first time in cord blood transplant patientsApr 29, 2015
Virus-specific cell therapy used in cord blood transplant patients successfully prevented 3 of the most problematic post-transplant viruses affecting this group of patients – cytomegalovirus, Epstein-Barr virus, and adenovirus.
Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014

Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.

Developmental transcription factors oversee glioma sub-typesOct 6, 2014
Researchers find transcription factors NFIA, Sox10 play important roles in the development of different subtypes of deadly brain tumors.
Dr. Malcolm Brenner receives prestigious lifetime achievement honor from Human Gene Therapy journal Aug 5, 2014
Renowned cell and gene therapy clinician-scientist Dr. Malcolm Brenner has received the prestigious Pioneer Award from the journal Human Gene Therapy.
New study advances safety, efficacy profile of virus-specific T cells for post-transplant recipientsJun 25, 2014
Using specialized, virus-specific immune cells called T cells, researchers have identified a novel safe, effective and rapid approach to protect from the threat of multiple severe infections at once.
Dr. Malcolm Brenner recipient of Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement AwardFeb 13, 2014
Renowned cell and gene therapy researcher Dr. Malcolm Brenner has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.
Grants support immunotherapy-based treatment for childhood cancerFeb 5, 2014
Two Baylor College of Medicine researchers have received grants from the nonprofit organization Alex’s Lemonade Stand Foundation to advance their immunotherapy-based treatment approaches for childhood cancer.
Activated “killer” T-cells effective against resistant lymphomaDec 16, 2013
Lab technique helps cells regain ability to attack tumor, according to new research from Baylor College of Medicine.
Center for Cell and Gene Therapy researchers receive V Foundation translational grantNov 14, 2013
Drs. Gianpietro Dotti, Cliona Rooney and Caridad Martinez received a $600,000, three-year grant to advance research into the prevention and treatment of complications associated with stem cell transplantation to cure leukemia.
'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell transplant patientsMay 14, 2013
Baylor College of Medicine researchers find a potential treatment for patients for whom antiviral drugs are not working.